1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccines for Infectious Diseases Market Perspective (2017-2028)
2.2 mRNA Vaccines for Infectious Diseases Growth Trends by Region
2.2.1 mRNA Vaccines for Infectious Diseases Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 mRNA Vaccines for Infectious Diseases Historic Market Size by Region (2017-2022)
2.2.3 mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2023-2028)
2.3 mRNA Vaccines for Infectious Diseases Market Dynamics
2.3.1 mRNA Vaccines for Infectious Diseases Industry Trends
2.3.2 mRNA Vaccines for Infectious Diseases Market Drivers
2.3.3 mRNA Vaccines for Infectious Diseases Market Challenges
2.3.4 mRNA Vaccines for Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue
3.1.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue (2017-2022)
3.1.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Players (2017-2022)
3.2 Global mRNA Vaccines for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Vaccines for Infectious Diseases Revenue
3.4 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio
3.4.1 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccines for Infectious Diseases Revenue in 2021
3.5 mRNA Vaccines for Infectious Diseases Key Players Head office and Area Served
3.6 Key Players mRNA Vaccines for Infectious Diseases Product Solution and Service
3.7 Date of Enter into mRNA Vaccines for Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Vaccines for Infectious Diseases Breakdown Data by Type
4.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Type (2017-2022)
4.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2023-2028)
5 mRNA Vaccines for Infectious Diseases Breakdown Data by Application
5.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Application (2017-2022)
5.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
6.2 North America mRNA Vaccines for Infectious Diseases Market Size by Type
6.2.1 North America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
6.2.2 North America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
6.2.3 North America mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
6.3 North America mRNA Vaccines for Infectious Diseases Market Size by Application
6.3.1 North America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
6.3.2 North America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
6.3.3 North America mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
6.4 North America mRNA Vaccines for Infectious Diseases Market Size by Country
6.4.1 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
6.4.2 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
7.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type
7.2.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
7.2.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
7.2.3 Europe mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
7.3 Europe mRNA Vaccines for Infectious Diseases Market Size by Application
7.3.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
7.3.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
7.3.3 Europe mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
7.4 Europe mRNA Vaccines for Infectious Diseases Market Size by Country
7.4.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
7.4.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
8.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type
8.2.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
8.2.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
8.2.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
8.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application
8.3.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
8.3.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
8.3.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
8.4 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region
8.4.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022)
8.4.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
9.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type
9.2.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
9.2.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
9.2.3 Latin America mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
9.3 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application
9.3.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
9.3.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
9.3.3 Latin America mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
9.4 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country
9.4.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
9.4.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
10.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type
10.2.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
10.2.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
10.2.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
10.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application
10.3.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
10.3.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
10.3.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
10.4 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country
10.4.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
10.4.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.1.5 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Vaccines for Infectious Diseases Introduction
11.2.4 CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.2.5 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Introduction
11.3.4 Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.3.5 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Vaccines for Infectious Diseases Introduction
11.4.4 BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.4.5 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.5.5 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.6.5 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Introduction
11.7.4 In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.7.5 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Introduction
11.8.4 eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.8.5 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Vaccines for Infectious Diseases Introduction
11.9.4 Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.9.5 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
11.10.5 Tiba Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
